{
  "guide": {
    "slug": "dusq-sleep-regulation-system",
    "archetype": "buyer",
    "title": "DUSQ Sleep Regulation System Buyer Guide",
    "subtitle": "A cautious preorder guide to DUSQ's behind-the-ear sleep-regulation wearable, evidence gap, safety limits, and buyer risk.",
    "summary": "DUSQ is a compelling preorder for early adopters interested in closed-loop sleep neurotechnology, but its own January 2026 clinical summary did not measure overnight sleep. Reserve only if you accept productization, evidence, safety, privacy, and shipping risk.",
    "category": {
      "slug": "neurotechnology",
      "name": "Neurotechnology",
      "description": "Consumer and research neurotechnology guides for headsets, sleep devices, EEG, stimulation systems, and brain-computer interfaces."
    },
    "tags": [
      "dusq",
      "sleep-tech",
      "neurotechnology",
      "wearables",
      "sleep-tracking",
      "preorder",
      "vagus-nerve-stimulation",
      "vestibular-stimulation",
      "biofeedback",
      "health-tech",
      "buyer-guide"
    ],
    "version": "2026-05-24.2",
    "publishedAt": "2026-05-24",
    "updatedAt": "2026-05-24",
    "freshness": "Checked against DUSQ official pages, Shopify product JSON, clinical summary, whitepaper, privacy/terms pages, investor context, and adjacent FDA/PubMed vestibular-stimulation references on 2026-05-22; spot-checked DUSQ product, homepage, and terms pages again on 2026-05-24. Re-check shipping timing, final launch price, refund handling, contraindications, regulatory claims, wellness-only disclaimers, and overnight PSG evidence before reserving or buying.",
    "heroLabel": "Sleep neurotech preorder",
    "vaultPath": "Research/Technology/Product Reviews/DUSQ Sleep Regulation System Buyer Guide.md",
    "r2JsonKey": "guides/dusq-sleep-regulation-system/2026-05-24.2.json",
    "commerce": {
      "disclosure": "Field Guides has no affiliate relationship with the DUSQ direct link in this guide. Prices are observed merchant snapshots, not live checkout prices.",
      "primaryLinkId": "dusq-early-access-direct",
      "priceApi": {
        "provider": "merchant-observed",
        "status": "not_configured",
        "note": "No live DUSQ price API is configured for this guide. Displayed prices are observed snapshots and should be checked with DUSQ before reserving or buying."
      },
      "links": [
        {
          "id": "dusq-early-access-direct",
          "merchant": "DUSQ",
          "title": "DUSQ Early Access",
          "label": "Check DUSQ early access",
          "description": "Direct DUSQ early-access product page. Confirm the reservation tier, refund language, final launch price, shipping date, consumable patch cost, and medical/safety limits before paying.",
          "url": "https://dusq.com/products/trackers-track-dusq-repairs",
          "relationship": "direct",
          "role": "target",
          "factCard": {
            "eyebrow": "Preorder",
            "summary": "Best fit only for early adopters comfortable reserving before independent shipped-unit reviews and overnight PSG outcomes are public.",
            "details": [
              "Observed Shopify variants were VIP at $5 and VIP Plus at $10 on 2026-05-22 and spot-checked on 2026-05-24.",
              "DUSQ says first-batch shipping is August 2026."
            ],
            "caveat": "Observed merchant snapshot, not live checkout or delivery proof."
          },
          "observedPrice": {
            "display": "$5-$10 reservation observed",
            "currency": "USD",
            "checkedAt": "2026-05-24",
            "source": "DUSQ Shopify product JSON and product page",
            "note": "Observed early-access reservation tiers; DUSQ advertises $229-$249 founding prices and $399 launch price, but checkout and terms should be re-checked."
          }
        }
      ]
    },
    "stats": [
      {
        "label": "Reservation",
        "value": "$5-$10",
        "detail": "Observed DUSQ Early Access Shopify variants on 2026-05-22 and spot-checked on 2026-05-24."
      },
      {
        "label": "Claimed launch",
        "value": "August 2026",
        "detail": "DUSQ says the first batch ships in August 2026."
      },
      {
        "label": "Clinical dataset",
        "value": "206 analyzed",
        "detail": "DUSQ clinical summary reports 212 randomized and 206 analyzed after withdrawals."
      },
      {
        "label": "Key gap",
        "value": "No PSG sleep outcome",
        "detail": "DUSQ's own clinical summary says overnight sleep was not measured in the January 2026 study."
      }
    ],
    "thesisCards": [
      {
        "label": "The product",
        "title": "DUSQ is trying to regulate sleep, not just score it.",
        "body": "The pitch combines behind-the-ear EDA/PPG sensing with automatic vagus and vestibular stimulation during the night."
      },
      {
        "label": "The catch",
        "title": "The public DUSQ-specific sleep proof is not finished.",
        "body": "The strongest DUSQ clinical document checked here measured sympathetic-surge proxies, not overnight sleep architecture or sleep efficiency."
      },
      {
        "label": "The buy",
        "title": "This is an early-adopter reservation, not a proven sleep appliance.",
        "body": "The reservation may make sense if you want first-batch access and can tolerate refund, shipping, evidence, privacy, and safety uncertainty."
      }
    ],
    "sections": [
      {
        "id": "bottom-line",
        "eyebrow": "Bottom line",
        "title": "DUSQ is worth watching, but most sleep buyers should wait.",
        "body": "DUSQ is a credible-looking sleep-neurotech preorder with an unusually direct claim: it says it detects autonomic disruption and responds with behind-the-ear stimulation. The risk-adjusted answer is to wait for production-unit reviews, independent use reports, and a DUSQ-specific overnight polysomnography study before treating it as a dependable sleep intervention. Reserve only if the small refundable deposit is really a bet on the category, not a purchase of proven sleep improvement."
      },
      {
        "id": "preorder-terms",
        "eyebrow": "Preorder",
        "title": "The current transaction is a reservation, not the finished device.",
        "table": {
          "columns": [
            "Area",
            "Observed DUSQ position",
            "Buyer read"
          ],
          "rows": [
            [
              "Reservation tiers",
              "Shopify product JSON showed VIP at $5 and VIP Plus at $10.",
              "Low-dollar exposure; DUSQ terms say pre-sale reservation amounts are refundable before shipping, but re-check the current terms before paying."
            ],
            [
              "Founding price",
              "Marketing page says $249 for VIP and $229 for VIP Plus, compared with $399 at launch.",
              "Useful only if DUSQ ships a product you still want when the balance is due."
            ],
            [
              "Shipping",
              "DUSQ says first batch ships in August 2026.",
              "Treat as an estimate until tracking, fulfillment, and post-ship support exist."
            ],
            [
              "Subscription",
              "Marketing copy says lifetime app access with no subscription.",
              "Good if durable; still verify whether advanced features, replacement patches, or future services change the ownership cost."
            ],
            [
              "Consumables",
              "FAQ says the starter pack includes 12 patches and refill packs are $25 for three months.",
              "Patch comfort, skin tolerance, refill availability, and recurring cost matter because the device sits behind the ear nightly."
            ]
          ]
        }
      },
      {
        "id": "evidence-gap",
        "eyebrow": "Evidence",
        "title": "The mechanism is plausible; the DUSQ sleep outcome is still the missing proof.",
        "body": "DUSQ's public evidence is strongest for a mechanism hypothesis: EDA can reflect sympathetic arousal, PPG adds cardiovascular context, and adjacent vestibular-stimulation work exists. The checked DUSQ clinical summary reports a randomized sham-controlled sympathetic-surge study, but it explicitly did not measure overnight sleep. That means DUSQ-specific claims about falling asleep faster, deeper sleep, fewer awakenings, or sleep architecture still need an overnight PSG trial or strong independent shipped-unit evidence."
      },
      {
        "id": "comparison-ladder",
        "eyebrow": "Ladder",
        "title": "DUSQ sits between passive trackers and regulated sleep stimulation.",
        "table": {
          "columns": [
            "Role",
            "Option",
            "What you gain",
            "What you give up"
          ],
          "rows": [
            [
              "Passive tracker",
              "Oura or WHOOP",
              "Mature sleep/recovery tracking, broad user base, more shipped-unit confidence.",
              "They mostly measure and coach; they do not claim automatic overnight neuromodulation."
            ],
            [
              "DUSQ preorder",
              "DUSQ Early Access",
              "Closed-loop sleep-regulation idea, behind-the-ear form factor, low reservation price, no-subscription promise.",
              "No public independent shipped-unit reviews and no DUSQ-specific overnight PSG outcome in the checked clinical summary."
            ],
            [
              "Regulated adjacent benchmark",
              "Modius Sleep",
              "FDA-cleared vestibular nerve stimulation category for chronic insomnia and a published sham-controlled trial.",
              "Different product, prescription context, session-based form factor, and not validation of DUSQ's combined closed-loop approach."
            ]
          ]
        }
      },
      {
        "id": "mechanism",
        "eyebrow": "Mechanism",
        "title": "DUSQ's technical bet is detect, dampen, restore.",
        "table": {
          "columns": [
            "Layer",
            "DUSQ claim",
            "Evidence read"
          ],
          "rows": [
            [
              "Sensing",
              "EDA behind the ear reads sympathetic activation while PPG adds heart-rate and HRV context.",
              "EDA is a real sympathetic-arousal signal, but DUSQ's exact behind-the-ear signal quality and algorithm performance need independent validation."
            ],
            [
              "Inference",
              "The device detects autonomic micro-arousals or surges in real time.",
              "The whitepaper describes the architecture; public diagnostic performance data were not found."
            ],
            [
              "Stimulation",
              "DUSQ stimulates vagus and vestibular pathways near the mastoid region.",
              "Adjacent nVNS/VeNS research supports plausibility, but DUSQ's combined protocol and overnight dosing need product-specific evidence."
            ],
            [
              "Outcome",
              "Marketing claims better deep sleep, HRV, and fewer awakenings within two weeks.",
              "Treat these as first-party claims until a DUSQ-specific overnight PSG study and independent reviews are public."
            ]
          ]
        }
      },
      {
        "id": "safety-medical",
        "eyebrow": "Safety",
        "title": "Do not use this as a medical workaround.",
        "body": "DUSQ's terms describe the services and device as wellness products only, not medical devices, not medical advice, and not intended to diagnose, treat, cure, prevent, or monitor any medical condition or disease. The terms also say DUSQ does not represent that the services will improve sleep, health, or wellness outcomes. DUSQ's FAQ says the product is not built for sleep apnea and is not a CPAP replacement. The contraindication list is material: implanted cardiac devices, deep brain stimulators, cochlear implants, implanted vagus-nerve stimulators, metallic implants in the head or neck, epilepsy or seizure disorders without medical supervision, pregnancy, and users under 18. If any of those are close to your situation, this is a clinician conversation before it is a checkout decision.",
        "bullets": [
          "If sleep apnea is possible, get evaluated rather than trying to stimulate around it.",
          "If you use CPAP, keep using it unless your sleep physician changes the plan.",
          "Do not treat DUSQ marketing claims as proof that it will improve your sleep or health outcomes.",
          "If stimulation causes pain, dizziness, tingling beyond the expected mild sensation, skin irritation, or sleep disruption, stop and seek medical guidance."
        ]
      },
      {
        "id": "privacy",
        "eyebrow": "Privacy",
        "title": "The privacy decision is real because DUSQ handles sensitive physiology.",
        "body": "DUSQ's privacy policy says the service may collect device sensor and measurement data, biometric information, health-related information, usage data, and account details. It also says personal information is stored and processed in the United States and may be accessed or transferred to India for operations, R&D, and technical functions. That is not unusual for a connected health product, but it should be part of the preorder decision because the value proposition depends on continuous physiological sensing."
      },
      {
        "id": "review-user-signal",
        "eyebrow": "Signal",
        "title": "The current public signal is mostly first-party or financially aligned.",
        "table": {
          "columns": [
            "Signal type",
            "What exists",
            "How to weight it"
          ],
          "rows": [
            [
              "First-party testimonials",
              "DUSQ publishes Gen 1-style user quotes and aggregate improvement claims.",
              "Useful for understanding the marketing promise, weak as proof."
            ],
            [
              "Investor/backer analysis",
              "Fireside Ventures describes DUSQ's overnight closed-loop device and clinical-validation ambition.",
              "Useful company context, but not independent product review."
            ],
            [
              "Independent reviews",
              "No shipped-unit professional review was found during this run.",
              "A key reason to wait if the product needs to work, not merely be interesting."
            ],
            [
              "Adjacent clinical evidence",
              "Modius Sleep has FDA and PubMed support for a different vestibular-stimulation device.",
              "Plausibility signal only; do not transfer the result directly to DUSQ."
            ]
          ]
        }
      },
      {
        "id": "decision-matrix",
        "eyebrow": "Decision",
        "title": "Who should reserve, wait, or skip.",
        "table": {
          "columns": [
            "Buyer",
            "Recommendation",
            "Why"
          ],
          "rows": [
            [
              "Neurotech early adopter",
              "Consider reserving",
              "The small deposit can be rational if you are funding a category bet and not depending on the outcome."
            ],
            [
              "Insomnia sufferer seeking a treatment",
              "Wait and speak with a clinician",
              "The DUSQ-specific public study checked here did not measure overnight sleep, and sleep disorders need diagnosis."
            ],
            [
              "CPAP or suspected apnea user",
              "Skip as a replacement",
              "DUSQ says it is not built for sleep apnea and is not a CPAP replacement."
            ],
            [
              "Privacy-sensitive buyer",
              "Wait",
              "The device's value depends on biometric and health-related data collection."
            ],
            [
              "Tracker buyer comparing Oura or WHOOP",
              "Decide the job first",
              "If you want mature tracking, buy a mature tracker. If you want intervention, DUSQ is the speculative choice."
            ]
          ]
        }
      },
      {
        "id": "cheat-sheet",
        "eyebrow": "Cheat sheet",
        "title": "The pre-check before paying more than the reservation.",
        "table": {
          "columns": [
            "Check",
            "Why it matters"
          ],
          "rows": [
            [
              "Has DUSQ published overnight PSG outcomes?",
              "The current clinical summary says direct sleep claims require that confirmation."
            ],
            [
              "Are independent shipped-unit reviews public?",
              "They expose comfort, adhesive, app, noise, support, and actual nightly adherence."
            ],
            [
              "Is the exact final price still $229-$249 for your tier?",
              "Reservation pages can change before launch."
            ],
            [
              "Are patch refills available and comfortable?",
              "Consumables and skin tolerance determine whether a behind-the-ear device survives nightly use."
            ],
            [
              "Do any contraindications apply?",
              "This is stimulation near the head/neck, not a passive ring."
            ]
          ]
        }
      },
      {
        "id": "bottom-line-repeat",
        "eyebrow": "Bottom line",
        "title": "Reserve for curiosity; wait for confidence.",
        "body": "DUSQ is one of the more interesting sleep-tech preorders because it targets intervention instead of another dashboard. That does not make it proven. The clean buyer move is to treat the $5-$10 reservation as optional early-access speculation and withhold real buying confidence until DUSQ shows overnight PSG sleep outcomes, shipped-unit reviews, clear regulatory wording, and post-launch support."
      }
    ],
    "claims": [
      {
        "id": "claim-reservation-price",
        "claim": "DUSQ Early Access had VIP and VIP Plus Shopify variants observed at $5 and $10 on 2026-05-22.",
        "sourceId": "dusq-product-json",
        "evidenceType": "merchant",
        "confidence": "high",
        "caveat": "Merchant product data can change without notice.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-shipping",
        "claim": "DUSQ says the first batch ships in August 2026.",
        "sourceId": "dusq-home",
        "evidenceType": "official",
        "confidence": "medium",
        "caveat": "Preorder shipping estimates can slip.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-founder-price",
        "claim": "DUSQ's marketing page says early access locks $249 for VIP or $229 for VIP Plus versus a stated $399 launch price.",
        "sourceId": "dusq-home",
        "evidenceType": "merchant",
        "confidence": "medium",
        "caveat": "Checkout and launch terms should be re-checked before paying more than the reservation.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-presale-refund",
        "claim": "DUSQ's terms say pre-sale reservation, pledge, or payment amounts are fully refundable before the product shipping date, for any reason or no reason.",
        "sourceId": "dusq-terms",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Refund terms can change, and post-shipping returns are subject to separate conditions.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-lifetime-app-access",
        "claim": "DUSQ's marketing page says early access includes lifetime app access with no subscription or annual fee.",
        "sourceId": "dusq-home",
        "evidenceType": "merchant",
        "confidence": "medium",
        "caveat": "DUSQ's terms reserve the right to suspend, modify, or discontinue services, so buyers should verify the current ownership model before paying.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-patch-refills",
        "claim": "DUSQ's FAQ says the starter pack includes 12 patches, each patch lasts one week with replaceable adhesive layers, and refill packs are $25 for three months.",
        "sourceId": "dusq-home",
        "evidenceType": "merchant",
        "confidence": "medium",
        "caveat": "Consumable pricing, availability, and comfort can change after launch.",
        "guideLocation": "Preorder",
        "sectionId": "preorder-terms"
      },
      {
        "id": "claim-dusq-study-size",
        "claim": "DUSQ's clinical evaluation summary reports 212 randomized participants and 206 analyzed participants.",
        "sourceId": "dusq-clinical-summary",
        "evidenceType": "official",
        "confidence": "medium",
        "caveat": "The document is sponsor-provided and marked confidential/proprietary.",
        "guideLocation": "Evidence",
        "sectionId": "evidence-gap"
      },
      {
        "id": "claim-first-party-sleep-marketing",
        "claim": "DUSQ's homepage makes first-party marketing claims of increased deep sleep, better HRV, and fewer night awakenings within two weeks.",
        "sourceId": "dusq-testimonials",
        "evidenceType": "official",
        "confidence": "low",
        "caveat": "Treat as first-party marketing/user-signal framing, not independent evidence; DUSQ's clinical summary did not measure overnight sleep outcomes.",
        "guideLocation": "Mechanism",
        "sectionId": "mechanism"
      },
      {
        "id": "claim-no-overnight-sleep",
        "claim": "DUSQ's clinical summary says the January 2026 study did not measure overnight sleep and that direct sleep claims need polysomnographic confirmation.",
        "sourceId": "dusq-clinical-summary",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Future DUSQ studies could change the evidence picture.",
        "guideLocation": "Evidence",
        "sectionId": "evidence-gap"
      },
      {
        "id": "claim-safety-events",
        "claim": "DUSQ's clinical summary reports no serious adverse events and mild transient skin redness or tingling in 3.9% of the active group.",
        "sourceId": "dusq-clinical-summary",
        "evidenceType": "official",
        "confidence": "medium",
        "caveat": "The analyzed study was short, single-site, and not an overnight use study.",
        "guideLocation": "Safety",
        "sectionId": "safety-medical"
      },
      {
        "id": "claim-not-apnea",
        "claim": "DUSQ's FAQ says the device is not built for sleep apnea and is not a CPAP replacement.",
        "sourceId": "dusq-home",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Users should confirm current contraindication and medical-use language before use.",
        "guideLocation": "Safety",
        "sectionId": "safety-medical"
      },
      {
        "id": "claim-wellness-only",
        "claim": "DUSQ's terms say the services and device are wellness products only, not medical devices, and are not intended to diagnose, treat, cure, prevent, or monitor any medical condition or disease.",
        "sourceId": "dusq-terms",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Regulatory and labeling language can change before or after launch.",
        "guideLocation": "Safety",
        "sectionId": "safety-medical"
      },
      {
        "id": "claim-no-outcome-representation",
        "claim": "DUSQ's terms say the company does not represent that the services will improve sleep, health, or wellness outcomes.",
        "sourceId": "dusq-terms",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "This disclaimer should be read alongside DUSQ's marketing claims before purchase.",
        "guideLocation": "Safety",
        "sectionId": "safety-medical"
      },
      {
        "id": "claim-contraindications",
        "claim": "DUSQ lists contraindications including implanted cardiac devices, deep brain stimulators, cochlear implants, implanted vagus nerve stimulators, metallic head/neck implants, epilepsy or seizure disorders without supervision, pregnancy, and users under 18.",
        "sourceId": "dusq-home",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Contraindication language may evolve with labeling and regulatory status.",
        "guideLocation": "Safety",
        "sectionId": "safety-medical"
      },
      {
        "id": "claim-privacy-data",
        "claim": "DUSQ's privacy policy says the service may collect device sensor/measurement data, biometric information, and health-related information.",
        "sourceId": "dusq-privacy",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Policy language can change; buyers should read the policy at setup.",
        "guideLocation": "Privacy",
        "sectionId": "privacy"
      },
      {
        "id": "claim-cross-border",
        "claim": "DUSQ's privacy policy says personal information is stored and processed in the United States and may be accessed or transferred to India for operations, R&D, and technical functions.",
        "sourceId": "dusq-privacy",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Data locations and subprocessors can change over time.",
        "guideLocation": "Privacy",
        "sectionId": "privacy"
      },
      {
        "id": "claim-modius-fda",
        "claim": "The FDA 510(k) summary for Modius Sleep identifies it as a non-invasive home-use neurostimulation device indicated to treat chronic insomnia in adults 22 and older.",
        "sourceId": "fda-modius-510k",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "This validates an adjacent device category, not DUSQ.",
        "guideLocation": "Ladder",
        "sectionId": "comparison-ladder"
      },
      {
        "id": "claim-modius-trial",
        "claim": "A 2024 PubMed-indexed Modius Sleep randomized sham-controlled trial reported a greater four-week ISI reduction for VeNS than sham.",
        "sourceId": "pubmed-modius-trial",
        "evidenceType": "lab",
        "confidence": "high",
        "caveat": "The result is for Modius Sleep, not DUSQ's combined closed-loop device.",
        "guideLocation": "Ladder",
        "sectionId": "comparison-ladder"
      },
      {
        "id": "claim-oura-subscription",
        "claim": "Oura's help page says membership costs $5.99/month or $69.99/year in the US and unlocks detailed features beyond three daily scores.",
        "sourceId": "oura-membership",
        "evidenceType": "official",
        "confidence": "high",
        "caveat": "Oura pricing and membership scope can change by region and date.",
        "guideLocation": "Ladder",
        "sectionId": "comparison-ladder"
      }
    ],
    "sources": [
      {
        "id": "dusq-home",
        "title": "DUSQ - World's Only Sleep Regulation System",
        "publisher": "DUSQ",
        "url": "https://dusq.com/",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "spec"
      },
      {
        "id": "dusq-product",
        "title": "DUSQ Early Access",
        "publisher": "DUSQ",
        "url": "https://dusq.com/products/trackers-track-dusq-repairs",
        "accessedAt": "2026-05-24",
        "sourceType": "merchant",
        "role": "commerce"
      },
      {
        "id": "dusq-product-json",
        "title": "DUSQ Early Access Shopify product JSON",
        "publisher": "DUSQ / Shopify",
        "url": "https://dusq.com/products/trackers-track-dusq-repairs.json",
        "accessedAt": "2026-05-24",
        "sourceType": "merchant",
        "role": "price"
      },
      {
        "id": "dusq-how-it-works",
        "title": "How It Works",
        "publisher": "DUSQ",
        "url": "https://dusq.com/pages/how-it-works",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "claim-support"
      },
      {
        "id": "dusq-clinical-summary",
        "title": "DUSQ Clinical Evaluation Summary v2.0.2",
        "publisher": "Ezymind Healthcare Private Limited",
        "url": "https://cdn.shopify.com/s/files/1/0725/0945/6454/files/DUSQ_Clinical_Evaluation_v2.0.2_7_1.pdf?v=1777611949",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "claim-support"
      },
      {
        "id": "dusq-whitepaper",
        "title": "The Micro-Arousal Hypothesis - DUSQ Research",
        "publisher": "DUSQ",
        "url": "https://cdn.shopify.com/s/files/1/0725/0945/6454/files/DUSQ_Microarousal_White_Paper.pdf?v=1777621292",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "claim-support"
      },
      {
        "id": "dusq-privacy",
        "title": "DUSQ Privacy Policy",
        "publisher": "DUSQ",
        "url": "https://dusq.com/policies/privacy-policy",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "background"
      },
      {
        "id": "dusq-terms",
        "title": "DUSQ Terms of Service",
        "publisher": "DUSQ",
        "url": "https://dusq.com/policies/terms-of-service",
        "accessedAt": "2026-05-24",
        "sourceType": "official",
        "role": "background"
      },
      {
        "id": "dusq-testimonials",
        "title": "DUSQ homepage testimonials and user claims",
        "publisher": "DUSQ",
        "url": "https://dusq.com/",
        "accessedAt": "2026-05-24",
        "sourceType": "community",
        "role": "community-signal"
      },
      {
        "id": "fireside-dusq",
        "title": "DUSQ: Engineering sleep, not just tracking it",
        "publisher": "Fireside Ventures",
        "url": "https://firesideventures.com/blogs/ignite/backing-dusq-engineering-sleep-not-just-tracking-it",
        "accessedAt": "2026-05-22",
        "sourceType": "inference",
        "role": "background"
      },
      {
        "id": "fda-modius-510k",
        "title": "Modius Sleep 510(k) Summary K230826",
        "publisher": "U.S. Food and Drug Administration",
        "url": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230826.pdf",
        "accessedAt": "2026-05-22",
        "sourceType": "official",
        "role": "background"
      },
      {
        "id": "pubmed-modius-trial",
        "title": "Repeated electrical vestibular nerve stimulation reduces severity in moderate to severe insomnia",
        "publisher": "PubMed / Brain Stimulation",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38797370/",
        "accessedAt": "2026-05-22",
        "sourceType": "lab",
        "role": "claim-support"
      },
      {
        "id": "oura-membership",
        "title": "Oura Membership",
        "publisher": "Oura Help",
        "url": "https://support.ouraring.com/hc/en-us/articles/4409086524819-Oura-Membership",
        "accessedAt": "2026-05-22",
        "sourceType": "official",
        "role": "background"
      },
      {
        "id": "whoop-peak",
        "title": "WHOOP Peak",
        "publisher": "WHOOP",
        "url": "https://www.whoop.com/us/en/peak/",
        "accessedAt": "2026-05-22",
        "sourceType": "official",
        "role": "background"
      }
    ]
  },
  "publicUrl": "https://fieldguides.co/g/dusq-sleep-regulation-system"
}